Horm Metab Res 2010; 42(2): 149-151
DOI: 10.1055/s-0029-1241170
Short Communication

© Georg Thieme Verlag KG Stuttgart · New York

Association of Genetic Variation in KCNQ1 with Type 2 Diabetes in the KORA Surveys

H. Grallert1 , 2 , C. Herder3 , C. Marzi2 , C. Meisinger1 , H.-E. Wichmann1 , 2 , W. Rathmann4 , T. Illig1 , 2
  • 1Helmholtz Zentrum München, National Research Centre for Environmental Health, Institute of Epidemiology, Neuherberg, Germany
  • 2IBE, Chair of Epidemiology, University of Munich, Germany
  • 3Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany
  • 4Institute of Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany
Weitere Informationen

Publikationsverlauf

received 17.06.2009

accepted 02.09.2009

Publikationsdatum:
01. Oktober 2009 (online)

Introduction

Besides variants in the TCF7L2 gene, 20 variants predisposing for type 2 diabetes (T2DM) in Caucasians have been identified in genome wide association (GWA) studies so far [1] [2]. The T2DM locus KCNQ1 (potassium voltage-gated channel, KQT-like subfamily, member 1) emerged from two GWA studies conducted in different independent Asian and Scandinavian populations [3] [4]. Both studies concordantly reported on rs2237895 as one of the polymorphisms that predispose to T2DM, but only Unoki et al. could demonstrate this association in a European sample [3] [4]. KCNQ1 encodes the pore-forming subunit of a voltage-gated K+ channel (KvLQT1) that is also expressed in brain, adipose tissues, and pancreas [5].

Many initial reports of disease associations could not be replicated in later studies [6]. Furthermore, probably due to bias and genuine population diversity, almost all initial findings regarding disease associations of genetic polymorphisms overestimated the effects [7]. Therefore, this study was designed to investigate the association of the KNCQ1 gene variant rs2237895 and T2DM in a large population-based sample in Southern Germany. We selected this variant, because of its highly significant association with T2DM in the European study sample in the study by Unoki et al., and because it was found to be associated with T2DM in both GWA studies. In order to better understand its pathogenetic relevance, we also investigated the association between rs2237895 and several glycemic traits.

References

  • 1 Herder C, Rathmann W, Strassburger K, Finner H, Grallert H, Huth C, Meisinger C, Gieger C, Martin S, Giani G, Scherbaum WA, Wichmann HE, Illig T. Horm Metab Res. 2008;  40 722-726
  • 2 Prokopenko I, McCarthy MI, Lindgren CM. Trends Genet.  2008;  24 613-621
  • 3 Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, Andersen G, Ng DP, Holmkvist J, Borch-Johnsen K, Jorgensen T, Sandbaek A, Lauritzen T, Hansen T, Nurbaya S, Tsunoda T, Kubo M, Babazono T, Hirose H, Hayashi M, Iwamoto Y, Kashiwagi A, Kaku K, Kawamori R, Tai ES, Pedersen O, Kamatani N, Kadowaki T, Kikkawa R, Nakamura Y, Maeda S. Nat Genet. 2008;  40 1098-110
  • 4 Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H, Hirota Y, Mori H, Jonsson A, Sato Y, Yamagata K, Hinokio Y, Wang HY, Tanahashi T, Nakamura N, Oka Y, Iwasaki N, Iwamoto Y, Yamada Y, Seino Y, Maegawa H, Kashiwagi A, Takeda J, Maeda E, Shin HD, Cho YM, Park KS, Lee HK, Ng MC, Ma RC, So WY, Chan JC, Lyssenko V, Tuomi T, Nilsson P, Groop L, Kamatani N, Sekine A, Nakamura Y, Yamamoto K, Yoshida T, Tokunaga K, Itakura M, Makino H, Nanjo K, Kadowaki T, Kasuga M. Nat Genet. 2008;  40 1092-1097
  • 5 Demolombe S, Franco D, de Boer P, Kuperschmidt S, Roden D, Pereon Y, Jarry A, Moorman AF, Escande D. Am J Physiol Cell Physiol. 2001;  280 C359-C372
  • 6 O’Rahilly S, Wareham NJ. N Engl J Med. 2006;  355 306-308
  • 7 Ioannidis JP, Ntzani EE, Trikalinos TA. Contopoulos-Ioannidis DG.  Nat Genet. 2001;  29 306-309
  • 8 Wichmann HE, Gieger C, Illig T. Gesundheitswesen. 2005;  67 ((Suppl. 1)) S26-S30
  • 9 Steffens M, Lamina C, Illig T, Bettecken T, Vogler R, Entz P, Suk EK, Toliat MR, Klopp N, Caliebe A, Konig IR, Kohler K, Ludemann J, Lacava AD, Fimmers R, Lichtner P, Ziegler A, Wolf A, Krawczak M, Nurnberg P, Hampe J, Schreiber S, Meitinger T, Wichmann HE, Roeder K, Wienker TF, Baur MP. Hum Hered. 2006;  62 20-29
  • 10 Lee YH, Kang ES, Kim SH, Han SJ, Kim CH, Kim HJ, Ahn CW, Cha BS, Nam M, Nam CM, Lee HC. J Hum Genet. 2008;  53 991-998
  • 11 Hu C, Wang C, Zhang R, Ma X, Wang J, Lu J, Qin W, Bao Y, Xiang K, Jia W. Diabetologia. 2009;  52 1322-1325
  • 12 Tan JT, Nurbaya S, Gardner D, Sandra Y, Tai ES, Ng DP. Diabetes. 2009;  58 1445-1449
  • 13 Müssig K, Staiger H, Machicao F, Kirchhoff K, Guthoff M, Schafer SA, Kantartzis K, Silbernagel G, Stefan N, Holst JJ, Gallwitz B, Haring HU, Fritsche A. Diabetes. 2009;  58 1715-1720

Correspondence

PD Dr. T. Illig

Institute of Epidemiology Helmholtz Zentrum München National Research Centre for Environmental Health

Ingolstädter Landstraße 1

85764 Neuherberg

Germany

Telefon: +49/89/3187 4249

Fax: +49/89/3187 4567

eMail: illig@helmholtz-muenchen.de